Abbott | ABT - Efectivo Y Equivalentes

Precio De Mercado
93.78
Cambio Diario
0.98 1.06%
Mensual
-7.95%
Anual
-28.14%
Q2 Expectativa
89.18




Efectivo Y Equivalentes Cambio Fecha
Abbott USD 8.52B 1.01B 2025-12
Agilent USD 1.76B 31M 2025-12
AtriCure USD 167.43M 19.56M 2025-12
Baxter International USD 1.97B 240M 2025-12
Becton, Dickinson and Co. USD 740M 99M 2025-12
Bio-Rad Laboratories USD 529.8M 134M 2025-12
Boston Scientific USD 1.96B 690M 2025-12
Cooper Companies USD 110.6M 14.3M 2025-09
Danaher USD 5.7B 1.09B 2026-03
Dexcom USD 917.7M 918M 2025-12
Edwards Lifesciences USD 2.4B 538M 2026-03
Globus Medical USD 526.16M 154.39M 2025-12
Insulet USD 716.1M 41.3M 2025-12
Integra LifeSciences USD 235.05M 2.86M 2025-12
Intuitive Surgical USD 7.98B 1.05B 2026-03
J&J USD 21.69B 1.98B 2026-03
Masimo USD 312.3M 162.7M 2025-09
Medtronic USD 1.15B 135M 2025-12
Merit Medical Systems USD 446.4M 53.95M 2025-12
Pfizer USD 1.34B 295M 2025-09
Solventum Corp USD 878M 764M 2025-12
Stryker USD 4.01B 755M 2025-12
Tandem Diabetes Care USD 90.63M 1.31M 2025-12
Teleflex USD 354M 100.3M 2025-09
Terumo JPY 217.16B 12.86B 2025-09
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
Zimmer Biomet Holdings USD 591.9M 700.8M 2025-12